Leadership Overview
Johnson & Johnson Services Inc has 10 executives leading key functions including strategy, financial oversight, operational management, and regional market development.
Focused on advancing global health outcomes, Johnson & Johnson Services Inc delivers transformative medical technologies and pharmaceutical solutions to patients and providers across diverse therapeutic areas worldwide.
Focused on advancing global health outcomes, Johnson & Johnson Services Inc delivers transformative medical technologies and pharmaceutical solutions to patients and providers across diverse therapeutic areas worldwide.
Leadership Roles at Johnson & Johnson Services Inc
Joaquin Duato - Chief Executive Officer
Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the overarching corporate strategy for the global healthcare enterprise. Overseeing the development of innovative medicines and medical technologies, the Chief Executive Officer ensures alignment across oncology, immunology, and neuroscience divisions. This leadership role involves driving long-term growth through rigorous investment in research and development. By managing complex international operations, Joaquin Duato maintains the competitive market position of the organization. The Chief Executive Officer collaborates with the Board to refine the mission of delivering advanced surgical products and medical devices to healthcare providers. Through constant evaluation of market trends, Duato secures the financial health of the company while expanding the reach of life-saving treatments. This executive focus remains on scaling high-impact healthcare solutions to meet the evolving needs of patients across all global markets.

Joaquin Duato - Chairman & Chief Executive Officer
Joaquin Duato, the Chairman & Chief Executive Officer at Johnson & Johnson Services Inc, governs the strategic direction and board-level initiatives for the entire healthcare portfolio. Managing the intersection of pharmaceutical innovation and medical device manufacturing, the Chairman & Chief Executive Officer ensures that corporate governance supports the delivery of advanced cardiovascular and immunology solutions. This leadership position involves setting the vision for global expansion and operational excellence. Joaquin Duato coordinates with executive leadership to optimize the research pipeline and accelerate the commercialization of new medical technologies. By fostering a culture of scientific advancement, the Chairman & Chief Executive Officer drives the company toward sustainable growth in competitive international sectors. This role requires balancing immediate operational demands with the long-term mission of improving patient outcomes. Through disciplined oversight, Duato maintains the integrity and market leadership of the organization in the global healthcare landscape.

Paulette Agne - Executive Assistant To President and Chief Executive Officer
Paulette Agne, the Executive Assistant To President and Chief Executive Officer at Johnson & Johnson Services Inc, manages the administrative workflow and strategic scheduling for the top leadership tier. Coordinating high-level communications, the Executive Assistant To President and Chief Executive Officer ensures that the office of the CEO maintains focus on critical healthcare initiatives and corporate priorities. This role involves facilitating interactions between the executive team and key stakeholders to streamline decision-making processes. Paulette Agne organizes complex operational agendas that support the development of pharmaceuticals and medical devices. By managing the flow of information, the Executive Assistant To President and Chief Executive Officer enables the leadership team to address urgent market challenges in oncology and neuroscience. This position requires precise attention to detail to support the global mission of the company. Through effective coordination, Agne enhances the efficiency of the executive office and contributes to the overall success of the organization.
Dominic Caruso - Chief Financial Officer
Dominic Caruso, the Chief Financial Officer at Johnson & Johnson Services Inc, manages the financial strategy, capital allocation, and fiscal reporting for the global organization. Overseeing the financial health of the pharmaceutical and medical technology divisions, the Chief Financial Officer ensures that resources support the research and development of innovative medicines. This leadership role involves directing financial planning and analysis to maintain the profitability of the company. Dominic Caruso coordinates with the executive team to evaluate investment opportunities in oncology, immunology, and neuroscience. By monitoring global economic trends, the Chief Financial Officer mitigates financial risks and ensures the long-term stability of the enterprise. This position requires rigorous oversight of financial operations to support the mission of delivering advanced surgical products to patients worldwide. Through disciplined fiscal management, Caruso enables the company to invest in future growth while maintaining a strong balance sheet and delivering value to stakeholders.
Salvatore Giovine - Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America)
Salvatore Giovine, the Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America) at Johnson & Johnson Services Inc, manages the financial operations and strategic budgeting for the North American pharmaceutical division. Overseeing the financial performance of innovative medicine portfolios, the Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America) ensures that resources are allocated to support the development of treatments in immunology and oncology. This leadership role involves directing financial planning to maximize the impact of medical investments in the region. Salvatore Giovine analyzes market data to guide the financial strategy for the launch of new medicines. By maintaining strict fiscal discipline, the Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America) supports the overall profitability of the North American business. This position requires close collaboration with regional leadership to ensure that financial goals align with the mission of improving patient care through advanced pharmaceutical solutions.

Ping Yang - Chief Operating Officer
Ping Yang, the Chief Operating Officer at Johnson & Johnson Services Inc, directs the global supply chain, manufacturing processes, and operational infrastructure for the company. Overseeing the production of pharmaceuticals and medical devices, the Chief Operating Officer ensures that the organization maintains high standards of quality and efficiency. This leadership role involves optimizing the manufacturing of surgical products and medical technologies to meet global demand. Ping Yang coordinates with regional leaders to streamline the distribution of medicines in oncology and neuroscience. By implementing advanced operational technologies, the Chief Operating Officer improves the agility of the supply chain and reduces costs. This position requires constant monitoring of production metrics to ensure that the company delivers life-saving products to healthcare providers on time. Through strategic operational management, Yang supports the mission of the organization by ensuring that the manufacturing and logistics functions remain robust and scalable.
Rowena Yeo - Vice President & Chief Information Officer (Asia Pacific)
Rowena Yeo, the Vice President & Chief Information Officer (Asia Pacific) at Johnson & Johnson Services Inc, directs the digital transformation and information technology strategy for the Asia Pacific region. Overseeing the implementation of data systems and cybersecurity, the Vice President & Chief Information Officer (Asia Pacific) ensures that the organization leverages technology to improve the delivery of medical devices and pharmaceuticals. This leadership role involves managing the IT infrastructure that supports research and development in neuroscience and cardiovascular care. Rowena Yeo coordinates with regional teams to integrate digital solutions that enhance operational efficiency and patient engagement. By driving innovation in data analytics, the Vice President & Chief Information Officer (Asia Pacific) enables the company to respond quickly to market changes in the region. This position requires a focus on building secure and scalable technology platforms to support the global mission of the company. Through strategic IT leadership, Yeo facilitates the digital advancement of the organization.

Wang Jiang - Managing Director
Wang Jiang, the Managing Director at Johnson & Johnson Services Inc, oversees regional operations and market penetration strategies for the company. Directing the implementation of pharmaceutical and medical technology distribution, the Managing Director ensures that healthcare providers receive essential surgical products and innovative medicines. This leadership role involves managing local teams to drive growth in specific geographic markets while maintaining compliance with global standards. Wang Jiang analyzes regional healthcare trends to tailor the delivery of immunology and cardiovascular solutions to local patient needs. By optimizing supply chain logistics and sales performance, the Managing Director strengthens the market presence of the organization. This position requires constant engagement with regional healthcare systems to identify opportunities for expansion. Through strategic management, Jiang supports the broader mission of the company by ensuring that advanced medical devices reach the intended patient populations efficiently and effectively across the assigned territory.
Liat Gottlieb - Managing Director
Liat Gottlieb, the Managing Director at Johnson & Johnson Services Inc, leads the operational execution and business development initiatives within the assigned market segment. Focusing on the commercialization of medical devices and pharmaceutical products, the Managing Director ensures that the company meets the specific demands of the local healthcare infrastructure. This role involves managing cross-functional teams to improve the accessibility of oncology and neuroscience treatments. Liat Gottlieb coordinates with regional partners to enhance the adoption of surgical products and medical technologies. By driving operational efficiency, the Managing Director supports the overall revenue goals and market impact of the organization. This position requires deep understanding of the regulatory environment and patient care requirements to maintain a competitive edge. Through strategic leadership, Gottlieb ensures that the company remains a trusted provider of healthcare solutions, consistently delivering value to patients and providers while expanding the footprint of the business.
Wagner Ferreira - Managing Director
Wagner Ferreira, the Managing Director at Johnson & Johnson Services Inc, directs the strategic growth and operational management of the company within the designated region. Overseeing the deployment of medical technologies and pharmaceutical solutions, the Managing Director ensures that the organization addresses critical healthcare needs in immunology and cardiovascular care. This role involves managing local business units to optimize the distribution of surgical products and medical devices. Wagner Ferreira leads initiatives to improve market share by aligning product offerings with the requirements of healthcare providers. By fostering strong relationships with regional stakeholders, the Managing Director facilitates the successful introduction of innovative medicines. This position requires a focus on operational excellence to ensure that the company maintains its reputation for quality and reliability. Through effective management, Ferreira drives the regional strategy, contributing to the global mission of improving patient health outcomes and sustaining the growth of the enterprise.
Explore Leadership Teams in Manufacturing
Founded in 2020, Viatris empowers people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions, and leverage their collective expertise to improve patient health. Viatris is headquartered in Canonsburg, Pennsylvania.
Company Leadership

GSK plc is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing innovative medicines, vaccines, and specialty healthcare products that address some of the world's most significant diseases. Headquartered in London, England, the company operates across numerous countries, serving patients, healthcare professionals, governments, hospitals, research institutions, and public health organizations. GSK generates the majority of its revenue through the development and sale of prescription medicines and vaccines while maintaining one of the largest research and development organizations within the global pharmaceutical industry.
Company Leadership LT
HB
JP
OA
Zydus is a global pharmaceutical company headquartered in Ahmedabad, India. Founded in 1952, the company operates manufacturing sites and research facilities across multiple states in India as well as in the United States and Brazil. Zydus specializes in developing, manufacturing, and distributing pharmaceutical products with a significant global footprint. The company maintains a strong presence in regulated markets including the United States, Europe, Latin America, and South Africa, while also serving numerous emerging markets worldwide. Zydus offers a comprehensive portfolio of pharmaceutical products and services, supported by extensive research and development capabilities.
Company Leadership
KT
DN
KM
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Company Leadership
RI
NB
CS